Overview

This activity is designed to efficiently discuss recent clinical advances in breast cancer oncology that hae emerged from presentations at recent international meetings including ASCO and SABCS.  the activity format will provide the opportunity for interaction between Penn Medicine faculty and meeting attendees with the aim of implementing new standards of patient care. Participants will gain up-to-date, practical information with immediate clinical application.

Learning Objectives

At the completion of this course, participants should be able to:

• Identify clinical trial evidence that allows for the personalization of care in the management of early and advanced forms of breast cancer according to breast cancer phenotype
• Implement current and evolving roles for prognostic and predictive biomarkers to stratify risk and inform clinical decision-making in the management of breast cancer 
• List recent clinical trial results concerning the use of novel breast cancer treatment strategies

Target Audience

The program is directed toward medical, surgical, and radiation oncologists, gynecologists, radiologists, primary care physicians, advanced practice clinicians, and other health care professionals involved in the treatment of patients with breast cancer.

For more information please visit the official event page.